Dirk Pauw - Montea CVA Chairman
| MONT Stock | EUR 65.80 2.40 3.79% |
Insider
Dirk Pauw is Chairman of Montea CVA
| Age | 67 |
| Phone | 32-0-53826262 |
| Web | https://www.montea.com |
Montea CVA Management Efficiency
The company has return on total asset (ROA) of 0.0276 % which means that it generated a profit of $0.0276 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2507 %, meaning that it generated $0.2507 on every $100 dollars invested by stockholders. Montea CVA's management efficiency ratios could be used to measure how well Montea CVA manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Mark Chadwick | Biotalys NV | N/A | |
| Filip Coremans | ageas SANV | 59 | |
| Haralambos David | Titan Cement International | 54 | |
| Marcel Cobuz | Titan Cement International | 52 | |
| Steven Braekeveldt | ageas SANV | 63 | |
| Afroditi Sylla | Titan Cement International | N/A | |
| Luc Vandecatseye | KBC Ancora | 65 | |
| Heidi Stieglitz | Melexis NV | 63 | |
| EfstratiosGeorgios Arapoglou | Titan Cement International | 68 | |
| Grigoris Dikaios | Titan Cement International | N/A | |
| Marc Biron | Melexis NV | 53 | |
| Toon Musschoot | Biotalys NV | N/A | |
| Leonidas Kanellopoulos | Titan Cement International | N/A | |
| Geert Reynders | Melexis NV | N/A | |
| Andreas Artemis | Titan Cement International | 65 | |
| Marc Ceuster | KBC Ancora | 57 | |
| Gijs Klarenbeek | Sequana Medical NV | 46 | |
| Fokion Tasoulas | Titan Cement International | N/A | |
| Gary Crist | ageas SANV | 66 | |
| Peter Durpel | Nextensa NV | 55 | |
| Vasileios Zarkalis | Titan Cement International | 58 | |
Management Performance
| Return On Equity | 0.25 | |||
| Return On Asset | 0.0276 |
Montea CVA Leadership Team
Elected by the shareholders, the Montea CVA's board of directors comprises two types of representatives: Montea CVA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Montea. The board's role is to monitor Montea CVA's management team and ensure that shareholders' interests are well served. Montea CVA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Montea CVA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Steven Claes, Chief Officer | ||
| Peter Demuynck, Chief Innovation | ||
| Christine Glas, Communication Mang | ||
| Jorg Heirman, S Gen | ||
| Jo BVBA, CEO MD | ||
| Dirk Pauw, Chairman | ||
| Els Vervaecke, Chief Officer | ||
| Jimmy Gysels, Chief Officer | ||
| Aurelie Cauter, Accounting Mang | ||
| Pauline Mahieu, Co Controller |
Montea Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Montea CVA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.25 | |||
| Return On Asset | 0.0276 | |||
| Profit Margin | 2.62 % | |||
| Operating Margin | 0.83 % | |||
| Current Valuation | 2.06 B | |||
| Shares Outstanding | 18.01 M | |||
| Shares Owned By Insiders | 16.20 % | |||
| Shares Owned By Institutions | 34.33 % | |||
| Price To Earning | 12.22 X | |||
| Price To Book | 1.00 X |
Pair Trading with Montea CVA
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Montea CVA position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Montea CVA will appreciate offsetting losses from the drop in the long position's value.Moving together with Montea Stock
Moving against Montea Stock
| 0.9 | ARGX | Argen X | PairCorr |
| 0.77 | MIKO | Miko NV | PairCorr |
| 0.42 | ACKB | Ackermans Van Haaren Earnings Call Today | PairCorr |
| 0.4 | SOLV | Solvac SA | PairCorr |
| 0.38 | MOUR | Moury Construct SA | PairCorr |
The ability to find closely correlated positions to Montea CVA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Montea CVA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Montea CVA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Montea CVA to buy it.
The correlation of Montea CVA is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Montea CVA moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Montea CVA moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Montea CVA can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Montea Stock Analysis
When running Montea CVA's price analysis, check to measure Montea CVA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Montea CVA is operating at the current time. Most of Montea CVA's value examination focuses on studying past and present price action to predict the probability of Montea CVA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Montea CVA's price. Additionally, you may evaluate how the addition of Montea CVA to your portfolios can decrease your overall portfolio volatility.